跳至主要内容
临床试验/NCT06101160
NCT06101160已完成不适用

Long-term Follow-up of Safety and Efficacy of OnabotulinumtoxinA for Treatment of Sialorrhea in Juvenile Cerebral Palsy

Cairo University1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2021年6月30日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
61
试验地点
1
主要终点
Drooling Severity Scale (DSS) and the Drooling Frequency Scale (DFS)

研究概览

简要总结

A 100 units of botulinum toxin was injected in both parotid and submandibular glands for children (2 - 12 years) with incapacitating sialorrhea in juvenile cerebral palsy patients and they are followed up for 1 year

详细描述

This was a prospective, longitudinal analysis with 1-year follow-up of 52 children with juvenile cerebral palsy (JCP) suffering from sialorrhea enrolled from 3 tertiary pediatric neurology rehabilitation centers (two in Cairo and one in Alexandria) and subjected to repeated BoNT-A injection.

The recruitment period was between June 30, 2021, until May 1, 2022 (the last patient follow-up ended on April 30, 2023).

Intervention: 100 units of OnabotulinumtoxinA (Botox®) were injected in the parotid and submandibular glands Follow-up visits: mo 1 post-injection (for every injection session) and every 3 months thereafter

In each visit; the following efficacy variables were assessed:

Primary outcome measures: The severity and frequency of sialorrhea evaluated by Drooling Severity Scale (DSS), and Drooling Frequency Scale (DFS) and visual-analogic ratings of familial distress (VAS-FD).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
4 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Juvenile cerebral palsy with age range (4 - 12 years)
  • Having severe drooling (DFS > 4)
  • Signing written informed consent by the legal guardians.

排除标准

  • Previous BoNT-A injection in the last three months
  • Patients receiving systemic medicine for the treatment of sialorrhea in the last 6 weeks
  • Any contraindications to treatment with BoNT

结局指标

主要结局

Drooling Severity Scale (DSS) and the Drooling Frequency Scale (DFS)

时间窗: 1 year

Each patient was assigned a severity rank according to the following grades: 1, dry: never drools; 2, mild: only the lips are wet; 3, moderate: wet on the lips and chin; 4, severe: drools to the extent that clothing becomes damp; 5, profuse: clothing, hands, tray, and objects become wet. The frequency of drooling was also rated as 1, never drools; 2, occasional drooling; 3, frequent drooling; and 4, constant drooling. The final drooling score is the summed ranking across both scales together to make a combined drooling ranking from 2 to 9.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hatem Samir Shehata

Professor of Neurology

Cairo University

研究点 (1)

Loading locations...

相似试验